The store will not work correctly when cookies are disabled.
4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)piperidin-4-yl acetate
ID: ALA3318845
Chembl Id: CHEMBL3318845
PubChem CID: 23364995
Max Phase: Preclinical
Molecular Formula: C23H25ClFNO3
Molecular Weight: 417.91
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
Standard InChI: InChI=1S/C23H25ClFNO3/c1-17(27)29-23(19-6-8-20(24)9-7-19)12-15-26(16-13-23)14-2-3-22(28)18-4-10-21(25)11-5-18/h4-11H,2-3,12-16H2,1H3
Standard InChI Key: DQMKFVKNNDMGTA-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 417.91 | Molecular Weight (Monoisotopic): 417.1507 | AlogP: 5.00 | #Rotatable Bonds: 7 |
Polar Surface Area: 46.61 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.24 | CX LogP: 4.10 | CX LogD: 3.20 |
Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.47 | Np Likeness Score: -0.53 |
References
1. Salama I, Löber S, Hübner H, Gmeiner P.. (2014) Synthesis and binding profile of haloperidol-based bivalent ligands targeting dopamine D(2)-like receptors., 24 (16): [PMID:25047579] [10.1016/j.bmcl.2014.06.079] |